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Changes in Dermal Fibroblasts from Abcc6 / Mice
Are Present before and after the Onset of Ectopic
Tissue Mineralization
Federica Boraldi1, Angelica Bartolomeo1, Qiaoli Li2, Jouni Uitto2 and Daniela Quaglino1
Pseudoxanthoma elasticum (PXE), a rare genetic disease caused by mutations in the ABCC6 gene, is characterized
by progressive calcification of elastic fibers in the skin, eyes, and the cardiovascular system. The pathomechanism
of the mineralization is still obscure. Several hypotheses have been proposed, one of them suggesting a role for
fibroblasts in controlling the amount and the quality of the calcified extracellular matrix. This hypothesis raises
the question whether changes in mesenchymal cells are the cause and/or the consequences of the calcification
process. In this study, fibroblasts were isolated and cultured from Abcc6þ /þ and Abcc6 / mice of different ages
to investigate parameters known to be associated with the phenotype of fibroblasts from PXE patients. Results
demonstrate that a few changes (Ank and Opn downregulation) are already present before the occurrence of
calcification. By contrast, a modification of other parameters (intracellular O2
 content, Tnap activity, and Bmp2
upregulation) can be observed in Abcc6 / mice after the onset of tissue mineralization. These data suggest that
in the Abcc6 / genotype, dermal fibroblasts actively contribute to changes that promote matrix calcification
and that these cells can be further modulated with time by the calcified environment, thus contributing to the
age-dependent progression of the disease.
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INTRODUCTION
Pseudoxanthoma elasticum (PXE) is a hereditary disease
caused primarily by mutations in the ABCC6 gene (Bergen
et al., 2000; Le Saux et al., 2000; Ringpfeil et al., 2000),
yet the mechanisms leading to elastic fiber mineralization
and consequently to clinical manifestations are not well
understood. A number of hypotheses have been proposed to
explain how lack or impaired function of ABCC6, a trans-
membrane transporter protein almost exclusively expressed in
the liver, can cause alterations in peripheral soft connective
tissues, including elastic fiber calcification in the skin, eyes,
and the arterial blood vessels (Quaglino et al., 2011; Li et al.,
2012). It has been proposed that ABCC6 transporter deficiency
may alter the availability of circulating factors, presumably
metabolized and secreted by the liver, which are
physiologically required to prevent aberrant calcifications
and are able to modulate the phenotype of mesenchymal
cells, such as fibroblasts (Ronchetti et al., 2013). As a
consequence of the abnormal protein profile of fibroblasts
(Boraldi et al., 2009), extracellular matrix components are
differentially synthesized and/or degraded and elastic fiber
mineralization ensues (Contri et al., 1996; Passi et al., 1996;
Quaglino et al., 2005; Gheduzzi et al., 2007). Alternatively,
it has been suggested that serum factors controlling soft
connective tissue calcification are abnormally secreted by
the liver and cause the calcification of elastic fibers. If this is
the case, changes in the characteristics of mesenchymal cells
could represent a secondary response to the mineralized
environment (Le Saux et al., 2006). A number of studies
have been performed demonstrating that PXE fibroblasts,
although isolated from patient tissues and cultured in an
optimal in vitro environment, maintain a number of charac-
teristics that clearly discriminate pathologic from healthy cells
(Ronchetti et al., 2013). Nevertheless, it is currently unclear
what changes occur in fibroblasts before mineralization of
elastic fibers and may be considered pathogenic for calcifica-
tion, and what changes represent the cellular response to the
mineralized environment. So far, all in vitro investigations on
PXE have been performed on fibroblasts isolated and cultured
from patients, i.e., from individuals who have been diagnosed
on the basis of clinical manifestations as a consequence of
calcification. Taking advantage of the PXE animal model,
which recapitulates the PXE phenotype including the slow
progression of tissue mineralization (Gorgels et al., 2005;
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Klement et al., 2005), the aim of this study was to compare
fibroblasts from congenic Abcc6 / (knockout, KO) mice
with those from Abc6þ /þ (wild type (WT)) mice. As calcifi-
cation in these animals occurs only after 5–6 weeks of age
(Klement et al., 2005), fibroblasts were isolated from KO and
WT mice at the age of 0.5 (absence of calcification) and 12
months (presence of calcification). A set of cellular parameters
that we have previously shown to be altered in dermal fibro-
blasts from PXE patients and to be related to mineralization
have been investigated (Boraldi et al., 2009, 2013). Therefore,
cells were characterized for their proliferative capabilities
and for their redox balance (Quaglino et al., 2000; Pasquali-
Ronchetti et al., 2006), on the basis of the intracellular
content of reactive oxygen species (ROS). Moreover, the expres-
sion of proteins exerting a key role in the development
of ectopic calcification (Giachelli 2005), such as bone
morphogenic protein 2 (Bmp2), osteopontin (Opn), pyrophos-
phatase/phosphodiesterase 1 (Enpp1), progressive ankylosis
protein (Ank), and tissue nonspecific alkaline phosphatase
(Tnap), was evaluated by western blot analysis, and their
Tnap activity (Boraldi et al., 2013) was assessed by
spectrophotometry.
RESULTS
Fibroblast proliferation capabilities
The number of fibroblasts that can be isolated from the skin of
mice is progressively lower with advancing age, and therefore
a higher number of adult animals was necessary to avoid
differences in the number of population doublings of fibro-
blasts from younger and older animals during all experimental
procedures. In contrast to human dermal fibroblasts, murine
cells reach senescence around passage 4. Therefore, fibro-
blasts, independently from their genotype, were studied only
at passages 2–3. Nevertheless, fibroblasts isolated from the
skin of adult mice have a lower capacity to replicate in vitro
compared with cells from younger animals and, when
observed by phase contrast microscopy, appeared larger with
cytoplasmic vacuoles (Figure 1a). Differences in the prolifera-
tion capabilities were independent from the genotype but
were clearly related to the animal’s age (Figure 1b).
Intracellular ROS content
As aging is characterized by an altered redox balance and an
oxidative stress has been demonstrated in PXE either in vitro or
in vivo, both in patients and in animal models (Pasquali-
Ronchetti et al., 2006; Garcia-Fernandez et al., 2008; Li et al.,
2008), the intracellular ROS content was evaluated in mouse
fibroblasts. Figure 2 shows that the H2O2 content is not
affected by age or by the genotype. Interestingly, there was
no difference in the amount of superoxide anion in fibroblasts
from young WT and KO mice, whereas there was a significant
increase in O2
 in fibroblasts from adult Abcc6 / mice
compared with that in cells grown from WT animals of the
same age or from younger Abcc6 / mice (Figure 2).
Protein expression
No differences in Bmp2 expression were observed in young WT
and KO animals (i.e., before the occurrence of calcification).
With age, a significant upregulation was observed only in cells
grown from adult KO animals (Figure 3).
Evaluation of Tnap protein expression revealed a significant
increase with mice age, without differences between WT and
KO animals (Figure 4). Similarly, Tnap activity was signifi-
cantly upregulated in fibroblasts from adult mice compared
with that in cells from younger mice (Figure 4). Moreover,
enzymatic activity was even higher (Po0.05) in cells from
adult KO mice compared with that in cells from WT mice of
the same age (Figure 4).
In murine dermal fibroblasts, Enpp1 expression was sig-
nificantly decreased in adult mice as compared with young
animals; however, no differences were observed between
Abcc6 / and Abcc6þ /þ mice (Figure 5).
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Figure 1. Dermal fibroblasts cultured from KO (Abcc6 / ) and WT
(Abcc6þ /þ ) mice of 0.5 and 12 months of age. Cells were observed by phase
contrast microscopy (a) and counted after 3 and 6 days fropm plating (b).
Differences in the proliferation capabilities are related to the age of the
animals, but are independent of the genotype as clearly shown in graph (b).
Bar ¼ 300mm. KO, knockout; WT, wild type.
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On the contrary, Abcc6 / mice, at all ages, were
characterized by a significantly lower expression of Ank
compared with that in WT animals. However, no changes
were noted between cells from young and adult animals
(Figure 5), indicating that this protein is not affected by the
animal’s age.
Osteopontin, a well-known inhibitor of the calcification
process, was significantly reduced in Abcc6 / fibroblasts
compared with cells from age-matched WT mice. Differences
were negligible with age (Figure 6), indicating that mouse
genotype is the main regulator of Opn expression.
CONCLUSIONS
Although we have made significant progress in understanding
the molecular basis of PXE, pathogenic mechanisms respon-
sible for the calcification of elastic fibers in this disease remain
to be clarified. Our understanding of PXE has been improved
by the development of transgenic mouse models by specifi-
cally inactivating the Abcc6 gene (Gorgels et al., 2005;
Klement et al., 2005). Consistently, Abcc6 / mice recapitu-
late several histopathological findings typical of PXE patients,
including the slowly progressive mineralization of connective
tissues in the skin, eyes, and the arterial blood vessels
(Klement et al., 2005; Jiang et al., 2007). The aim of this
study was to investigate fibroblasts isolated from the skin of
Abcc6 / and Abcc6þ /þ mice. Moreover, animals of two
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Figure 2. Anion superoxide (O2
 ) and hydrogen peroxide (H2O2) content
measured by flow cytometry in dermal fibroblasts cultured from WT
(Abcc6þ /þ ) and KO (Abcc6 / ) mice of 0.5 and 12 months of age.
*Po0.05, KO vs. WT mice of the same age; #Po0.05, 0.5 vs. 12 months of age
within the same genotype. KO, knockout; WT, wild type.
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Figure 3. Expression of Bmp2 measured by western blot in dermal fibroblasts
cultured from WT (Abcc6þ /þ ) and KO (Abcc6 / ) mice of 0.5 and 12
months of age. Data are expressed as mean values±SD of densitometric
analyses, where values in cells from WT animals 0.5 months of age were set at
1. A representative western blot is shown. *Po0.05, KO versus WT mice of the
same age; ##Po0.01, 0.5 vs. 12 months within the same genotype. KO,
knockout; WT, wild type.
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Figure 4. Tnap expression and activity were evaluated in dermal fibroblasts
cultured from WT (Abcc6þ /þ ) and KO (Abcc6 / ) mice of 0.5 and
12 months of age. Data are expressed as mean values±SD of different
measurements where values in cells from WT animals aged 0.5 months were
set at 1. A representative western blot is shown. *Po0.05, KO versus WT mice
of the same age; ##Po0.01 and ###Po0.001, 0.5 vs. 12 months within the
same genotype. KO, knockout; WT, wild type.
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different ages were used to compare the behavior of cells
before with that after the onset of calcification. The present
study design can identify changes that, when preceding
ectopic mineralization, could contribute to the development
of pathologic calcification, as well as differences that, when
observed after the occurrence of mineralization, are possibly
induced by the modified environment. To exclude changes
simply related to the animal’s aging, we have compared age-
matched WT with KO mice (Table 1). The choice of this
model was predicated on a number of reasons: (a) This mouse
model allows the analysis of cells from tissues before animals
with the Abcc6 / genotype develop calcification, a con-
dition that cannot be evaluated in humans as the
histopathological diagnosis of PXE is routinely made after
the onset of clinical manifestations, i.e., when the mineral
precipitates are already present in tissues; (b) Fibroblasts are an
excellent model for studying PXE, as they maintain an in vitro
pathological phenotype (Quaglino et al., 2000, 2005)
exhibiting oxidative stress parameters (Pasquali-Ronchetti
et al., 2006) and an altered protein profile (Boraldi et al.,
2009, 2013). In this study, we have investigated the occur-
rence of oxidative stress and the expression of a number of
proteins that are involved in the calcification process and, in
particular, in the phosphate-related pathways, as we have
hypothesized that they have a key role in the development
and/or progression of soft connective tissue calcification in
PXE (Li et al., 2012, 2013; Boraldi et al., 2013). Our results
demonstrated that murine dermal fibroblasts, in contrast
to human dermal fibroblasts (Boraldi et al., 2010), exhibit
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Figure 5. Pyrophosphatase/phosphodiesterase 1 (Enpp1) and ankylosis protein (Ank) expression measured by western blot in dermal fibroblasts cultured from
WT (Abcc6þ /þ ) and KO (Abcc6 / ) mice of 0.5 and 12 months of age. Data are expressed as mean values±SD of densitometric analyses where values in cells
from WT animals aged 0.5 months were set at 1. Representative western blots are shown. **Po0.01 KO versus WT mice of the same age; ##Po0.01, 0.5 vs. 12
months within the same genotype. KO, knockout; WT, wild type.
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Figure 6. Expression of osteopontin (Opn) measured by western blot in
dermal fibroblasts cultured from WT (Abcc6þ /þ ) and KO (Abcc6 / ) mice
of 0.5 and 12 months of age. Data are expressed as mean values±SD of
densitometric analyses where values in cells from WT animals aged 0.5
months were set at 1. A representative western blot is shown. *Po0.05 and
**Po0.01 KO versus WT mice of the same age. KO, knockout; WT, wild type.
Table 1. Influence of genotype (WT vs. KO) and aging
(0.5 vs. 12 months) on the expression of cellular
parameters
Changes influenced by
Parameters Genotype Age
O2: content Yes Yes
Bmp2: expression Yes Yes
Tnap
Expression No Yes
Activity Yes Yes
Enpp1: expression No Yes
Ank: expression Yes No
Opn: expression Yes No
Abbreviations: AnK, progressive ankylosis protein; Bmp2, bone morpho-
genic protein 2; Enpp1, pyrophosphatase/phosphodiesterrase 1; KO,
knockout; O2, oxygen; Opn, osteopontin; Tnap, tissue nonspecific alkaline
phosphatase; WT, wild type.
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in vitro morphological features and proliferative capabilities
that vary dependent on the animal’s age and independently
of the genotype. Therefore, the absence of the Abcc6 gene
activity does not affect the proliferation potential of
mesenchymal cells.
Replicative senescence in many in vitro models, including
dermal fibroblasts, has been associated with increased ROS
content (Lawless et al., 2012). Altered redox balance is a
frequent condition common to many disorders both in the
absence or in the presence of ectopic calcification (Byon
et al., 2008), and has been demonstrated to be related to the
severity of clinical manifestations in patients with PXE and
PXE-like disorders (Garcia-Fernandez et al., 2008; Boraldi
et al., 2013). As only fibroblasts from adult Abcc6 / mice
were shown to have higher levels of O2
 , oxidative stress is
likely the consequence of the calcified environment.
Consistent with this conclusion, it has been demonstrated in
the PXE animal model that antioxidant treatment can
ameliorate the redox balance, without affecting the extent of
mineralization (Li et al., 2008).
Bmp2 expression is essential for osteoblastic differentiation
of mesenchymal cells and therefore it has been widely impli-
cated in the development of vascular calcification (Derwall
et al., 2012). Recent studies have shown that BMP2 is
upregulated by ROS, being at the same time an inducer of
ROS accumulation (Mandal et al., 2011), and favoring
alkaline phosphatase activity, and phosphate accumulation
(Rawadi et al., 2003). In accordance, we have shown that
Bmp2, in association with ectopic calcification and with ROS
accumulation, is significantly upregulated in fibroblasts from
adult Abcc6 / mice. Therefore, these data support the
hypothesis that when calcification is initiated, there is a
stimulatory loop that further increases mineral deposition
and alters the phenotypic behavior of fibroblasts. A key
question relates to the factors that are capable of triggering
the initial phase of ectopic calcification in specific areas of soft
connective tissues. We have already demonstrated that Tnap
activity is significantly upregulated in fibroblasts from PXE
patients, suggesting that phosphate metabolism has a role in
the pathogenesis of elastic fiber calcification (Boraldi et al.,
2013). Present data further indicate that there is an age-
dependent upregulation of Tnap expression and Tnap activity
in fibroblasts from Abcc6 / mice. Alkaline phosphatase acts
on phosphate-containing substrates by releasing inorganic
phosphate that can accumulate in the extracellular matrix
and, under favorable conditions of the microenvironment, can
precipitate in the form of hydroxyapatite crystals. One of these
substrates is the calcification inhibitor inorganic pyrophos-
phate (PPi), which is generated by Enpp1 through hydrolysis of
adenosine triphosphate and is transported to the extracellular
milieu by Ank. Assessment of the expression of these proteins
indicated that both the age and the genotype of mice
contribute to phenotypic changes of the fibroblasts.
In particular, our data demonstrated that, at all time points,
Abcc6 / fibroblasts have a lower expression of Ank, a pro-
tein that is necessary for providing the extracellular environ-
ment with adequate amounts of physiological calcification
inhibitors, including PPi. When Ank is downregulated, soft
connective tissue becomes increasingly prone to mineraliza-
tion. As this process gradually progresses with increased age of
the animals, fibroblasts are modified toward a phenotype that
favors mineral precipitation (i.e., lower Enpp1 and increased
Tnap expression and activity). These observations are in
agreement with the concept that ectopic calcification is more
frequently observed in aged individuals.
Interestingly, besides PPi, other factors control mineral
deposition in the extracellular matrix, including osteopontin,
a well-known inhibitor of vascular calcification (Scatena et al.,
2007), as it regulates apatite crystal size and growth most
likely by its ability to directly bind to specific apatite crystal
faces (Speer et al., 2002). The marked downregulation of Opn
expression observed in fibroblasts from Abcc6 / mice at all
ages, together with lower PPi availability and a progressive
Tnap-mediated release of Pi from the PPi pool in older mice,
may act in synergy to promote mineral deposition.
In this study, a comparison of a number of parameters,
before and after the onset of mineral deposition in tissues of
PXE mice, demonstrated that there are changes in dermal
fibroblasts that can be related to the genotype and that are
present well before the development of calcification. Such
changes possibly represent a trigger of calcification, whereas
other changes may reflect a cellular response to the calcified
environment that further sustains the mineralization process.
Finally, the observation that Ank expression is significantly
reduced in fibroblasts from the young Abcc6 / mice
supports the hypothesis that phosphate metabolism is locally
altered in PXE (Boraldi et al., 2013) and that reduced transport
of the calcification inhibitor PPi in the extracellular
compartment together with impaired carboxylation of Matrix
Gla Protein (Gheduzzi et al., 2007; Li et al., 2007; Boraldi
et al., 2013) may be the key players for the initial deposition of
mineral precipitates in the absence of Abcc6 transport activity.
In conclusion, our data demonstrate that, although grown in
optimal culture conditions, dermal fibroblasts from KO mice,
similar to human PXE fibroblasts, exhibit and maintain in vitro
peculiar characteristics. Therefore, at least few of the differ-
ences in protein expression are related to the genotype,
whereas other parameters are modulated both by the genotype
and by the age of the animals (Table 1). Although it cannot be
excluded that circulating factors in vivo exert an epigenetic
modulation on the fibroblast phenotype, the present data
support the role of mesenchymal cells, such as fibroblasts in
the mineralization process. These cells exhibit a differential
expression of molecules related to the calcification process
before ectopic calcification takes place within tissues, thus
excluding the hypothesis that these changes are the conse-
quence of the mineralized environment. Within this context,
Ank and Opn may represent two potential pharmacologic
targets warranting further investigation in the search for novel
therapies for PXE.
MATERIALS AND METHODS
Cells
Dermal fibroblast cultures were obtained from the whole skin of 37
Abcc6 / and 29 Abcc6þ /þ mice of 0.5 (n¼ 27) and 12 months
(n¼ 39) of age. The study was approved by the Ethical Committee of
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the University of Modena and Reggio Emilia. Fibroblasts were
cultured in DMEM (Gibco, Grand Island, New York, NY) with 10%
fetal bovine serum (Lonza, Basel, CH) and were used at 2nd or 3rd
passages. During all experimental procedures, fibroblasts were
pooled from several animals of the same age and genotype. Cells
were routinely cultured in 75 cm2 flasks (Nunc, Roskilde, Denmark)
with DMEM supplemented with 10% fetal bovine serum, penicillin
100 IU ml 1, streptomycin 100mg ml 1, and nonessential amino
acids 1X (Gibco). Cells were observed by phase contrast microscopy.
Flow cytometry
ROS analysis was performed on proliferating cells as previously
described (Boraldi et al., 2009). Briefly, cells were stained with
dihydroethidium (DH2, 1 mM) and 2’,7’-dichlorodihydrofluorescein
diacetate (H2DCF-DA, 2 mM) probes (Molecular Probes, Eugene, OR)
for the determination of superoxide anion O2
 and hydrogen
peroxide (H2O2), respectively. Cells were analyzed on an EPICS XL
flow cytometer (Beckman Coulter, Brea, CA) at the emission wave-
lengths of 575 and 520 nm. Ten thousand events were collected and
evaluated for each treatment using a WINMDI 2.8 program.
Experiments were performed in duplicate and repeated twice.
Western blot
Cells were homogenized in RIPA buffer with protease inhibitors
(Sigma, St Louis, MO), centrifuged, and supernatants collected and
stored at  80 1C until analysis. Protein concentration was measured
in each sample according to Bradford assay (Bradford, 1976) to load
equal amounts of protein. After separation by 1D PAGE, proteins
were transferred to nitrocellulose and incubated with anti-Ank, anti-
Opn, anti-Bmp2 (Abcam, Cambridge, UK); anti-Enpp1 and anti-Tnap
(Santa Cruz Biotechnology, Santa Cruz, CA), followed by appropriate
horseradish peroxidase–conjugated secondary antibodies (Abcam).
Experiments were performed at least two times with all different cell
lines.
Alkaline phosphatase activity
Fibroblasts were detached by enzymatic treatment and washed
three times with PBS. Cells were lysed by appropriate buffer contain-
ing 0.1% Triton X-100 (Sigma). Cell lysate (20ml) was mixed with
100ml of Tris-glycine buffer, pH 10.3 (50 mM Tris-HCl, 100 mM
glycine, and 2 mM MgCl2), and 100ml of p-nitrophenyl phosphate
(Sigma). The reaction mix was incubated at 37 1C for 30 min and the
reaction was stopped by adding 50ml of 3 M NaOH. Absorbance was
measured at 405 nm in a microplate reader. Enzymatic activity was
normalized to total protein concentration using BSA as a standard for
the Bradford protein detection method (Bradford, 1976). Control
samples were set as one. Experiments were performed three times
in duplicate.
Data analysis
Data were expressed as mean values ±SD of all measurements and
were compared by the Mann–Whitney or by the Anova test with
significance at Po0.05. Statistical data were obtained using Graph-
Pad software 5.0 (San Diego, CA).
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